Koronare mikrovaskuläre Dysfunktion – 40 Jahre unterschätzt

Im Jahr 1985 wurde der Ausdruck „mikrovaskuläre Angina“ von Cannon und Epstein eingeführt für Patienten mit pektanginösen Beschwerden trotz unauffälliger Koronarangiografie [1]. In den letzten 20 Jahren konnten bezüglich der koronaren mikrovaskulären Dysfunktion (MVD) zwar diagnostische Erfolge erzielt werden, die Frage nach effektiven Therapiestrategien ist jedoch immer noch schwer zu beantworten.

Schlüsselwörter

koronare mikrovaskuläre Dysfunktion - Echografie - Koronarangiografie - Therapie - Sinus-Reducer

• Literatur

• 1 Cannon 3rd RO, Epstein SE. “Microvascular angina” as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol 1988; 61: 1338-1343
• 2 Jespersen L, Hvelplund A, Abildstrom SZ. et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J 2012; 33: 734-744
• 3 Ong P, Camici PG, Beltrame JF. et al. International standardization of diagnostic criteria for microvascular angina. Int J Cardiol 2018; 250: 16-20
• 4 Gdowski MA, Murthy VL, Doering M. et al. Association of Isolated Coronary Microvascular Dysfunction With Mortality and Major Adverse Cardiac Events: A Systematic Review and Meta-Analysis of Aggregate Data. J Am Heart Assoc 2020; 9: e014954
• 5 Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dysfunction: an update. Eur Heart J 2014; 35: 1101-1111
• 6 Del Buono MG, Montone RA, Camilli M. et al. Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review. J Am Coll Cardiol 2021; 78: 1352-1371
• 7 Kunadian V, Chieffo A, Camici PG. et al. An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. Eur Heart J 2020; 41: 3504-3520
• 8 Caiati C, Montaldo C, Zedda N. et al. Validation of a new noninvasive method (contrast-enhanced transthoracic second harmonic echo Doppler) for the evaluation of coronary flow reserve: comparison with intracoronary Doppler flow wire. J Am Coll Cardiol 1999; 34: 1193-1200
• 9 Schindler TH, Schelbert HR, Quercioli A. et al. Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. JACC Cardiovasc Imaging 2010; 3: 623-640
• 10 Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 2007; 356: 830-840
• 11 Ong P, Safdar B, Seitz A. et al. Diagnosis of coronary microvascular dysfunction in the clinic. Cardiovasc Res 2020; 116: 841-855
• 12 Knuuti J, Wijns W, Saraste A. et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020; 41: 407-477
• 13 Ho KT, Ong HY, Tan G. et al. Dynamic CT myocardial perfusion measurements of resting and hyperaemic blood flow in low-risk subjects with 128-slice dual-source CT. Eur Heart J Cardiovasc Imaging 2015; 16: 300-306
• 14 Rahman H, Corcoran D, Aetesam-Ur-Rahman M. et al. Diagnosis of patients with angina and non-obstructive coronary disease in the catheter laboratory. Heart 2019; 105: 1536-1542
• 15 Ford TJ, Stanley B, Good R. et al. Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina: The CorMicA Trial. J Am Coll Cardiol 2018; 72: 2841-2855
• 16 Taqueti VR, Di Carli MF. Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options: JACC State-of-the-Art Review. J Am Coll Cardiol 2018; 72: 2625-2641
• 17 Skalidis EI, Hamilos MI, Chlouverakis G. et al. Ivabradine improves coronary flow reserve in patients with stable coronary artery disease. Atherosclerosis 2011; 215: 160-165
• 18 Nalbantgil S, Altintiğ A, Yilmaz H. et al. The Effect of Trimetazidine in the Treatment of Microvascular Angina. Int J Angiol 1999; 8: 40-43
• 19 Elliott PM, Krzyzowska-Dickinson K, Calvino R. et al. Effect of oral aminophylline in patients with angina and normal coronary arteriograms (cardiac syndrome X). Heart 1997; 77: 523-526
• 20 Rakhimov K, Gori T. Non-pharmacological Treatment of Refractory Angina and Microvascular Angina. Biomedicines 2020; 8: 285
• 21 Pan X, Bao H, Si Y. et al. Spinal Cord Stimulation for Refractory Angina Pectoris: A Systematic Review and Meta-analysis. Clin J Pain 2017; 33: 543-551
• 22 Konigstein M, Giannini F, Banai S. The Reducer device in patients with angina pectoris: mechanisms, indications, and perspectives. Eur Heart J 2018; 39: 925-933